Severe Aortic Stenosis: Clinical Trials

3 trials for Severe Aortic Stenosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Not yet recruiting 2, Completed 1

Follow Severe Aortic Stenosis: new trials by email Literature Review of Severe Aortic Stenosis trials Research Report on Severe Aortic Stenosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of TAVI at Experienced Interventional Cardiac Centers Without On-site Cardiac Surgery (ATLAS Study)
Transcatheter Aortic Valve Replacement (TAVR) with surgical oversight, Transcatheter Aortic Valve Replacement (TAVR) without surgical oversight - Aortic Stenosis, Severe Aortic Stenosis
Phase 4Not yet recruitingUniversity of Alberta6002026-12-012026-10-27
Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)
Angiotensin Receptor Blocker (ARB) - Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy
Phase 4Not yet recruitingSeoul National University Hospital6322026-08-152026-07-29
Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
desmopressin - Acquired Von Willebrand Disease Secondary to Severe Aortic Stenosis, Heye´s Syndrome
Phase 4CompletedPontificia Universidad Catolica de Chile132009-06-012017-04-05

Narrower conditions

Aortic Valve Stenosis (3)  ·  Hypertrophy, Left Ventricular (1)

Broader conditions

Aortic Valve Disease (3)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Heart Valve Diseases (3)  ·  Ventricular Outflow Obstruction (3)  ·  Cardiomegaly (1)  ·  Hypertrophy (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Angiotensin Receptor Antagonists (1)  ·  Deamino Arginine Vasopressin (1)  ·  Transcatheter Aortic Valve Replacement (1)

Sponsors

Pontificia Universidad Catolica de Chile (1)  ·  Seoul National University Hospital (1)  ·  University of Alberta (1)

Countries

Canada (1)  ·  Chile (1)  ·  South Korea (1)